A flow cytometric assay for simultaneous assessment of drug efflux, proliferation, and apoptosis
A flow cytometric assay for simultaneous assessment of drug efflux, proliferation, and apoptosis
复制标题
DOI:
10.1002/cyto.b.20004
复制
发表时间:
2004-05-01
影响因子:
3.4
通讯作者:
Boutonnat, J
中科院分区:
文献类型:
--
作者:
Barbier, M;Gray, BD;Boutonnat, J
Background: Proliferative status and multidrug resistance play a key role in determining cell response to chemotherapy. There is a need to develop multiple labeling method that allows simultaneous assessment of multidrug resistant (MDR) phenotype, proliferative status, apoptosis related changes in mitochondrial potential, in chemosensitive and chemoresistant tumor cell populations.Methods: A three-color labeling was performed using Hoechst 33342 (DNA), JC1 (mitochondrial potential), and a far red fluorescent membrane intercalating dye: PTIR271 (proliferation).Results: Combined staining of DNA and mitochondrial potential allows identification of subpopulations expressing and MDR phenotype mediated by P-glycoprotein (Pgp), and, in Pgp negative subpopulations, identification of apoptotic cells and evaluation of cell cycle status in viable cells. Addition of a far red fluorescent membrane intercalating dye, PTIR271, allows simultaneous monitoring of cell division status by dye dilution in both drug sensitive and drug resistant populations.Conclusion: This triple labeling is an interesting method to study the proliferation status of drug sensitivity and drug resistance in viable tumor cells. (C) 2004 Wiley-Liss, Inc.